Kentucky 2022 Regular Session

Kentucky Senate Bill SB293

Introduced
3/2/22  
Refer
3/2/22  

Caption

AN ACT relating to coverage for hearing aids and related services.

Impact

The enactment of SB 293 is expected to significantly influence the landscape of health insurance coverage in Kentucky, particularly for state employees. By mandating coverage for hearing aids, the bill ensures that individuals who suffer from hearing loss will have increased access to necessary medical devices without incurring prohibitive out-of-pocket costs. This legislative action aligns with broader public health objectives, promoting better auditory health and communicative abilities for citizens who rely on these devices for their daily life.

Summary

Senate Bill 293 is an act that addresses coverage for hearing aids and related services for state employees in Kentucky. This bill mandates that health benefit plans provide coverage for hearing aids that are deemed medically necessary, as well as related services such as audiological assessments and fittings. The legislation sets forth guidelines aiming to enhance accessibility to hearing aids for individuals who are hard of hearing or deaf, requiring insurance providers to establish minimum coverage stipulations. The goal is to reduce the financial burden on families needing these essential tools for better communication and quality of life.

Sentiment

Overall, the sentiment surrounding SB 293 is positive, particularly among advocacy groups representing individuals who are hard of hearing and deaf. Supporters argue that the bill is a critical step toward inclusivity and ensuring that all Kentuckians can access the tools they need for effective communication. However, some skepticism exists regarding the adequacy of the mandated coverage limits, as concerns arise about whether the bill adequately addresses the varying costs of hearing aids that individuals may encounter, particularly for advanced models or specific needs.

Contention

Despite the overall support for the bill, there are notable points of contention among stakeholders. Critics of SB 293 often highlight concerns regarding the definitions of 'reasonable' and 'customary' pricing for hearing aids and whether the coverage provided is sufficient to meet varying patient needs. Additionally, discussions around compliance and how insurance providers will implement these coverage requirements may arise as challenges. The bill also places an onus on the insurance sector, which may face pushback regarding increased costs associated with broader coverage.

Companion Bills

No companion bills found.

Similar Bills

KY HB412

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY HB68

AN ACT relating to coverage for injectable epinephrine devices.

KY HB98

AN ACT relating to coverage for hepatitis C virus infection testing and treatment in pregnant women.

KY HB183

AN ACT relating to coverage for injectable epinephrine devices.

KY HB709

AN ACT relating to mental health coverage in connection with pregnancy.

KY HB55

AN ACT relating to coverage of mental health wellness examinations.

KY HB768

AN ACT relating to coverage for cranial conditions.

KY HB556

AN ACT relating to coverage for injectable epinephrine devices.